Brain Advance Access originally published online on May 6, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain, Vol. 126, No. 6, 1358-1370,
June 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg146
TNF-induced death of adult human oligodendrocytes is mediated by c-jun NH2-terminal kinase-3
Departments of 1 Neurology and 2 Neurosurgery, Medical University of Lodz, Lodz, Poland
Correspondence to: Krzysztof Selmaj, MD, PhD, Department of Neurology, Medical University of Lodz, 22 Kopcinskiego Street, 90-153 Lodz, Poland E-mail: kselmaj{at}afazja.am.lodz.pl
Tumour necrosis factor (TNF) induces death of oligodendrocytes, the putative cell target in multiple sclerosis. We defined that the intracellular transduction pathway involved in TNF-induced death of human adult oligodendrocytes (hOLs) is dependent on c-jun NH2-terminal kinase (JNK) activation, but not the other mitogen-activated protein kinase (MAPK), p38. JNK activation, measured by c-jun phosphorylation and induction of the phosphorylated form of JNK, was enhanced, prolonged and correlated with cell death in hOLs exposed to TNF. Comparative autoradiographic analysis revealed that JNK-3, but not JNK-1 or JNK-2, is responsible for prolonged JNK activation in TNF exposed hOLs. Expression of a dominant-negative mutant of JNK upstream kinase, MKK4/SEK1, inhibited apoptosis induced by TNF, whereas expression of a constitutive active mutant of MEKK1, an upstream kinase to JNK, accelerates TNF-induced apoptosis. JNK activation occurred prior to changes of mitochondrial membrane potential in hOLs exposed to TNF. These results demonstrate that TNF-induced death in adult hOLs depends on prolonged JNK-3 activation, and that this apoptosis requires the mitochondrial dysfunction that occurs after JNK activation. This is the first evidence that a JNK-3 isoform is involved in oligodendrocyte death and might have significant importance in designing new molecules to protect hOLs demise in multiple sclerosis.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Melani, S. Cipriani, M. G. Vannucchi, D. Nosi, C. Donati, P. Bruni, M. G. Giovannini, and F. Pedata Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia Brain, June 1, 2009; 132(6): 1480 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cudrici, F. Niculescu, T. Jensen, E. Zafranskaia, M. Fosbrink, V. Rus, M. L. Shin, and H. Rus C5b-9 Terminal Complex Protects Oligodendrocytes from Apoptotic Cell Death by Inhibiting Caspase-8 Processing and Up-Regulating FLIP. J. Immunol., March 1, 2006; 176(5): 3173 - 3180. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jurewicz, M. Matysiak, K. Tybor, L. Kilianek, C. S. Raine, and K. Selmaj Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor Brain, November 1, 2005; 128(11): 2675 - 2688. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Felts, A.-M. Woolston, H. B. Fernando, S. Asquith, N. A. Gregson, O. J. Mizzi, and K. J. Smith Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide Brain, July 1, 2005; 128(7): 1649 - 1666. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Druzhyna, S. I. Musiyenko, G. L. Wilson, and S. P. LeDoux Cytokines Induce Nitric Oxide-mediated mtDNA Damage and Apoptosis in Oligodendrocytes: PROTECTIVE ROLE OF TARGETING 8-OXOGUANINE GLYCOSYLASE TO MITOCHONDRIA J. Biol. Chem., June 3, 2005; 280(22): 21673 - 21679. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bhattacharya, R. M. Ray, and L. R. Johnson Prevention of TNF-{alpha}-induced apoptosis in polyamine-depleted IEC-6 cells is mediated through the activation of ERK1/2 Am J Physiol Gastrointest Liver Physiol, March 1, 2004; 286(3): G479 - G490. [Abstract] [Full Text] [PDF] |
||||



